Evidence map›Paper›PMID 32423040›Full record

ArticleNutrients2020

Plasma Trans Fatty Acid Levels, Cardiovascular Risk Factors and Lifestyle: Results from the Akershus Cardiac Examination 1950 Study.

Anupam Chandra, Magnus Nakrem Lyngbakken, Ivar Anders Eide, Helge Røsjø, Thea Vigen, Håkon Ihle-Hansen, Eivind Bjørkan Orstad, Ole Morten Rønning, Trygve Berge, Erik Berg Schmidt and 3 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01555411 (Akershus Cardiac Examination 1950 Study - a Cohort Study on Cardio- and Cerebrovascular Disease in 62-65-year-old Subjects), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01555411 active not recruitingnot on this map

Akershus Cardiac Examination 1950 Study - a Cohort Study on Cardio- and Cerebrovascular Disease in 62-65-year-old Subjects

TypeobservationalSponsorVestre Viken Hospital TrustRan2012 to 2050Enrolled3,706ConditionsAtrial Fibrillation, Heart Failure, Mild Cognitive Impairment, Cardiovascular Diseases
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Anupam ChandraDepartment of Renal Medicine, Division of Medicine, Akershus University Hospital, 1478 Lørenskog, Norway.
Magnus Nakrem LyngbakkenInstitute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.
Ivar Anders EideDepartment of Renal Medicine, Division of Medicine, Akershus University Hospital, 1478 Lørenskog, Norway.
Helge RøsjøInstitute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.
Thea VigenInstitute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.
Håkon Ihle-HansenDepartment of Medical Research, Bærum Hospital, Vestre Viken Hospital Trust, 3004 Drammen, Norway.
Eivind Bjørkan OrstadDivision of Medicine, Akershus University Hospital, 1478 Lørenskog, Norway.
Ole Morten RønningInstitute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.
Trygve BergeDepartment of Medical Research, Bærum Hospital, Vestre Viken Hospital Trust, 3004 Drammen, Norway.
Erik Berg SchmidtDepartment of Cardiology, Aalborg University Hospital, 9000 Aalborg, Denmark.
Arnljot TveitInstitute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.
Torbjørn OmlandInstitute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.
My SvenssonDepartment of Renal Medicine, Division of Medicine, Akershus University Hospital, 1478 Lørenskog, Norway.
University of Oslo · NOAkershus University Hospital · NOVestre Viken Hospital Trust · NOAalborg University Hospital · DK

Funding

Akershus Universitetssykehus N/AHelsedirektoratet N/AHelse Sør-Øst RHF N/AUniversitetet i Oslo N/AVestre Viken HF N/A
6 · The paper itself

Abstract

Intake of industrially produced trans fatty acids (iTFAs) has previously been associated with dyslipidemia, insulin resistance, hypertension and inflammation, as well as increased cardiovascular (CV) morbidity and mortality. iTFA intake declined in Norway after the introduction of legislative bans against iTFA consumption. However, the relationship between the current iTFA intake and CV health is unclear. The aim of the present study was to investigate the association between current iTFA intake, reflected by plasma iTFA levels, and established CV risk factors. We also examined the associations between plasma ruminant TFA levels and CV risk factors. In this cross-sectional study, we included 3706 participants from a Norwegian general population, born in 1950 and residing in Akershus County, Norway. The statistical method was multivariable linear regression. Plasma iTFA levels were inversely associated with serum triglycerides (

Indexed as

Life StyleAgedBlood GlucoseBlood PressureBody Mass IndexCardiovascular DiseasesC-Reactive ProteinCross-Sectional StudiesDietDietary FatsDiet SurveysEatingFastingFeeding BehaviorFemaleHeart Disease Risk FactorsBlood GlucoseC-Reactive ProteinDietary FatsTrans Fatty AcidsTriglyceridescardiovascular healthcardiovascular risk factorsindustrial trans fatty acidslegislative bansruminant trans fatty acids

Identifiers

PMID32423040
PMCPMC7284775
OpenAlexW3025275637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.